From the Departments of Medical Joint Materials and.
J Biol Chem. 2014 Mar 21;289(12):8135-50. doi: 10.1074/jbc.M113.509331. Epub 2014 Feb 6.
Although bone morphogenic protein (BMP) signaling promotes chondrogenesis, it is not clear whether BMP-induced chondrocyte maturation is cell-autonomously terminated. Loss of function of Smpd3 in mice results in an increase in mature hypertrophic chondrocytes. Here, we report that in chondrocytes the Runx2-dependent expression of Smpd3 was increased by BMP-2 stimulation. Neutral sphingomyelinase 2 (nSMase2), encoded by the Smpd3 gene, was detected both in prehypertrophic and hypertrophic chondrocytes of mouse embryo bone cartilage. An siRNA for Smpd3, as well as the nSMase inhibitor GW4869, significantly enhanced BMP-2-induced differentiation and maturation of chondrocytes. Conversely, overexpression of Smpd3 or C2-ceramide, which mimics the function of nSMase2, inhibited chondrogenesis. Upon induction of Smpd3 siRNA or GW4869, phosphorylation of both Akt and S6 proteins was increased. The accelerated chondrogenesis induced by Smpd3 silencing was negated by application of the Akt inhibitor MK2206 or the mammalian target of rapamycin inhibitor rapamycin. Importantly, in mouse bone culture, GW4869 treatment significantly promoted BMP-2-induced hypertrophic maturation and calcification of chondrocytes, which subsequently was eliminated by C2-ceramide. Smpd3 knockdown decreased the apoptosis of terminally matured ATDC5 chondrocytes, probably as a result of decreased ceramide production. In addition, we found that expression of hyaluronan synthase 2 (Has2) was elevated by a loss of Smpd3, which was restored by MK2206. Indeed, expression of Has2 protein decreased in nSMase2-positive hypertrophic chondrocytes in the bones of mouse embryos. Our data suggest that the Smpd3/nSMase2-ceramide-Akt signaling axis negatively regulates BMP-induced chondrocyte maturation and Has2 expression to control the rate of endochondral ossification as a negative feedback mechanism.
虽然骨形态发生蛋白(BMP)信号促进软骨生成,但尚不清楚 BMP 诱导的软骨细胞成熟是否自主终止。Smpd3 基因在小鼠中的功能丧失导致成熟肥大软骨细胞增加。在这里,我们报告说在软骨细胞中,BMP-2 刺激可增加依赖 Runx2 的 Smpd3 表达。中性鞘磷脂酶 2(nSMase2),由 Smpd3 基因编码,在小鼠胚胎骨软骨的预肥大和肥大软骨细胞中均有检测到。Smpd3 的 siRNA 以及 nSMase 抑制剂 GW4869 可显著增强 BMP-2 诱导的软骨细胞分化和成熟。相反,Smpd3 的过表达或 C2-神经酰胺,模拟 nSMase2 的功能,抑制软骨生成。在诱导 Smpd3 siRNA 或 GW4869 后,Akt 和 S6 蛋白的磷酸化均增加。Smpd3 沉默诱导的加速软骨生成被 Akt 抑制剂 MK2206 或雷帕霉素(mTOR)抑制剂 rapamycin 消除。重要的是,在小鼠骨培养中,GW4869 处理显著促进 BMP-2 诱导的软骨细胞肥大成熟和钙化,随后被 C2-神经酰胺消除。Smpd3 敲低减少了终末成熟的 ATDC5 软骨细胞的凋亡,可能是由于神经酰胺产生减少。此外,我们发现 Smpd3 的缺失会增加透明质酸合酶 2(Has2)的表达,而这种表达可被 MK2206 恢复。事实上,Has2 蛋白的表达在胚胎小鼠骨骼中 nSMase2 阳性肥大软骨细胞中减少。我们的数据表明,Smpd3/nSMase2-神经酰胺-Akt 信号轴负调节 BMP 诱导的软骨细胞成熟和 Has2 表达,以控制软骨内骨化的速度,作为一种负反馈机制。